---
aliases: /news/cue-health-to-develop-omicron-specific-test-through-hhs-partnership
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - Cue Health to develop omicron-specific test through HHS partnership
categories:
  - 'Medical Subject Headings (MeSH): Coronavirus Infections'
  - "Healthcare IT News: Health and Human Services\_(HHS)"
categorySlug:
  - 'medical subject headings (mesh): coronavirus infections'
  - "healthcare it news: health and human services\_(hhs)"
categoryUrl:
  - topic/medical-subject-headings-mesh-coronavirus-infections
  - topic/healthcare-it-news-health-and-human-services-hhs
categoryLabel:
  - Coronavirus Infections
  - "Health and Human Services\_(HHS)"
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2022-01-10'
description: >-
  HHS' Biomedical Advanced Research and Development Authority will provide
  additional funds to its ongoing partnership with San Diego-based Cue Health, a
  healthcare technology company, to develop an omi
favIconImage: null
featuredImage:
  alt: Cue Health to develop omicron-specific test through HHS partnership
  format: JPEG
  href: 43b9b1e0-9dec-543d-bb25-704cbd1aaca8-featuredImage.jpeg
  size:
    - 600
    - 800
  valid: true
  workPackage: 10762
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/20578/content
featuredPdf: null
htmlMetaData:
  author: Naomi Diaz
  description: >-
    HHS' Biomedical Advanced Research and Development Authority will provide
    additional funds to its ongoing partnership with San Diego-based Cue Health,
    a healthcare technology company, to develop an omicron-genotyping COVID-19
    test.
  generator: null
  viewport: 'width=device-width, initial-scale=1'
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: >-
    HHS' Biomedical Advanced Research and Development Authority will provide
    additional funds to its ongoing partnership with San Diego-based Cue Health,
    a healthcare technology company, to develop an omicron-genotyping COVID-19
    test.
  ogimage: null
  ogsite_name: null
  ogtitle: Cue Health to develop omicron-specific test through HHS partnership
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: >-
    Cue Health, COVID-19, HHS' Biomedical Advanced Research and Development
    Authority, healthcare, healthcare technology, ongoing, additional, funds,
    advanced, san
id: 10762
identifier: News
lastMod: '2022-01-10T11:55:56.793705Z'
link:
  brand: beckershospitalreview.com
  href: >-
    https://www.beckershospitalreview.com/innovation/cue-health-to-develop-omicron-specific-test-through-hhs-partnership.html
  original: >-
    https://www.beckershospitalreview.com/innovation/cue-health-to-develop-omicron-specific-test-through-hhs-partnership.html
href: >-
  https://www.beckershospitalreview.com/innovation/cue-health-to-develop-omicron-specific-test-through-hhs-partnership.html
original: >-
  https://www.beckershospitalreview.com/innovation/cue-health-to-develop-omicron-specific-test-through-hhs-partnership.html
mastHead: NEWS
mdName: 43b9b1e0-9dec-543d-bb25-704cbd1aaca8.md
openGraphMetaData:
  ogdescription: >-
    HHS' Biomedical Advanced Research and Development Authority will provide
    additional funds to its ongoing partnership with San Diego-based Cue Health,
    a healthcare technology company, to develop an omicron-genotyping COVID-19
    test.
  ogtitle: Cue Health to develop omicron-specific test through HHS partnership
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.beckershospitalreview.com/innovation/cue-health-to-develop-omicron-specific-test-through-hhs-partnership.html
  medigyTopics:
    - 'Medical Subject Headings (MeSH): Coronavirus Infections'
    - "Healthcare IT News: Health and Human Services\_(HHS)"
  sourceUrl: >-
    https://www.beckershospitalreview.com/innovation/cue-health-to-develop-omicron-specific-test-through-hhs-partnership.html
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  beckershospitalreview-cue-health-to-develop-omicron-specific-test-through-hhs-partnership
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: Cue Health to develop omicron-specific test through HHS partnership
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Healthcare IT Consulting Services
    permalink: /offering/healthcare-it-consulting-services
    categories:
      - 'KLAS: Strategy, Growth & Consolidation Consulting'
      - "Healthcare IT News: Health and Human Services\_(HHS)"
    offeringId: 5992
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    HHS' Biomedical Advanced Research and Development Authority will provide
    additional funds to its ongoing partnership with San Diego-based Cue Health,
    a healthcare technology company, to develop an omicron-genotyping COVID-19
    test.
  twittertitle: Cue Health to develop omicron-specific test through HHS partnership
  twitterimage: >-
    https://www.beckershospitalreview.com/templates/beckers/assets/images/bhr-og-image.png
  twitterurl: null
---
<p>HHS' Biomedical Advanced Research and Development Authority will provide additional funds to its ongoing <a href="https://www.prnewswire.com/news-releases/cue-health-to-develop-omicron-genotyping-covid-19-test-in-partnership-with-the-us-department-of-health-and-human-services-biomedical-advanced-research-and-development-authority-barda-301455080.html">partnership</a> with San Diego-based Cue Health, a healthcare technology company, to develop an omicron-genotyping COVID-19 test.</p><p>The test will complement the already existing Cue molecular COVID-19 test and will be compatible with the Cue Health Monitoring System and the Cue Health Mobile Application, according to a Jan. 6 press release.</p><p>"An omicron-specific test will assist clinicians in providing patients better treatment options and containment strategies at the time of a positive diagnosis," Cue CEO Ayub Khattak said in the press release.</p><p>Since 2018, HHS' BARDA has funded Cue Health projects like over-the-counter influenza diagnostic cartridges for its monitoring system and its portable COVID-19 test.</p>